Key result
Short-term treatment with HDL or S1P at the onset of reperfusion significantly reduced infarct size by ~50% in response to 30 min ischaemia in ex vivo experiments.
Why the study?
Does short-term treatment with HDL or S1P reduce infarct size and modulate Cx43 gap junctions in neonatal rat cardiomyocytes?
Does short-term treatment with HDL or S1P reduce infarct size and modulate Cx43 gap junctions in neonatal rat cardiomyocytes?
Effect estimate: ~50% reduction
Short-term treatment with HDL or S1P induces PKC-dependent phosphorylation of Cx43, reducing gap junction permeability to large molecules while maintaining impulse conduction, and conferring cardioprotection against ischaemia/reperfusion injury.
Should not alter reperfusion strategies; leaves open translation of HDL/S1P cardioprotection beyond ex vivo models.
AIMS: High-density lipoprotein (HDL) is known for its cardioprotective properties independent from its cholesterol transport activity. These properties are mediated by activation of kinases such as protein kinase C (PKC). Connexin43 (Cx43) is a gap junction protein present in ventricular cardiomyocytes. PKC-dependent phosphorylation modifies Cx43 gap junction channel properties and is involved in cardioprotection. We hypothesized that cardioprotective properties of HDL may be mediated in part by affecting Cx43 gap junction channels. METHODS AND RESULTS: Neonatal rat cardiomyocytes were treated with HDL and Cx43 phosphorylation was evaluated by western blotting and immunofluorescence. We found that HDL promoted phosphorylation of Cx43 with a maximal induction at 5 min, which was inhibited by pre-treatment with various PKC inhibitors. Sphingosine-1-phosphate (S1P), a component of HDL, induced effects that were similar to those of HDL. These compounds significantly reduced diffusion of fluorescent dye among cardiomyocytes (∼50%) which could be prevented by PKC inhibition. As observed during optical recordings of transmembrane voltage, HDL and S1P depressed impulse conduction only minimally (<5%). Moreover, 5 min of HDL and S1P treatment at the onset of reperfusion significantly reduced infarct size (∼50%) in response to 30 min ischaemia in ex vivo experiments. CONCLUSION: Short-term treatment with HDL or S1P induces phosphorylation of Cx43 by a PKC-dependent pathway. HDL-induced phosphorylation of Cx43 reduced the diffusion of large tracer molecules between cells, whereas impulse conduction was maintained. Moreover, 5 min treatment with HDL confers cardioprotection against ischaemia/reperfusion injury. These results link Cx43 for the first time to the short-term cardioprotective effects of HDL.
No takes yet. Share an insight, caveat, or question.
Morel et al. (2011) studied Ischaemia/reperfusion injury. HDL and Sphingosine-1-phosphate (S1P) was evaluated on Infarct size (~50% reduction). Short-term treatment with HDL or S1P at the onset of reperfusion significantly reduced infarct size by ~50% in response to 30 min ischaemia in ex vivo experiments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: